SpyBiotech Revenue and Competitors
Estimated Revenue & Valuation
- SpyBiotech's estimated annual revenue is currently $4.3M per year.
- SpyBiotech's estimated revenue per employee is $155,000
Employee Data
- SpyBiotech has 28 Employees.
- SpyBiotech grew their employee count by 8% last year.
SpyBiotech's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | President, Co-founder Chief Scientific Officer | Reveal Email/Phone |
4 | Co-founder and Scientific Advisor | Reveal Email/Phone |
5 | VP Finance and Operations | Reveal Email/Phone |
6 | Laboratory Manager | Reveal Email/Phone |
7 | Senior Clinical Project Manager | Reveal Email/Phone |
8 | Office Manager and Company Administrator | Reveal Email/Phone |
9 | Principal Scientist | Reveal Email/Phone |
10 | Principal Scientist | Reveal Email/Phone |
SpyBiotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is SpyBiotech?
SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimises delivery risk and enhances immunogenicity and efficacy. SpyBiotech has the exclusive rights from the University of Oxford to apply, commercialise and sub-license the SpyTag/SpyCatcher technology in vaccine development. The company's current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for 2021. SpyBiotech is supported by high quality investors including Oxford Sciences Innovation (OSI), the capital investor for the University of Oxford, and GV (formally Google Ventures). The company has raised £15 million of funding to date.
keywords:N/A
N/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Oxford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.8M | 28 | 8% | N/A |
#2 | $5M | 29 | -3% | N/A |
#3 | $4.6M | 29 | -3% | N/A |
#4 | $3.7M | 29 | -3% | N/A |
#5 | $9M | 29 | 107% | N/A |